2 completed, 1 active not recruiting, 1 recruiting, 1 unknown. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow B Cell Non-Hodgkin's Lymphoma: new trials by email Literature Review of B Cell Non-Hodgkin's Lymphoma trials Research Report on B Cell Non-Hodgkin's Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In VIVO CAR-T Therapy for Relapsed/Refractory Hematological Malignancies Invivo CAR-T - B-Acute Lymphoblastic Leukemia, B Cell Non-Hodgkin's Lymphoma | Phase 1 | Recruiting | Chongqing Precision Biotech Co., Ltd | 24 | 2025-07-01 | 2025-11-20 |
| A Study of C-CAR039 in Subjects With Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma CD19/CD20-directed Chimeric Antigen Receptor T Cells - B Cell Non-Hodgkin's Lymphoma | Phase 1 | Completed | Peking University | 3 | 2021-07-20 | 2026-01-30 |
| CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) CB-010, Cyclophosphamide, Fludarabine - Lymphoma, Non-Hodgkin, Relapsed Non Hodgkin Lymphoma | Phase 1 | Active not recruiting | Caribou Biosciences, Inc. | 72 | 2021-05-26 | 2026-10-19 |
| Does CMV Induced Changes in NK Lymphocyte Biology Influence the Effectiveness of Antibody Therapy Used to Treat B Cell Lymphoproliferative Diseases? B Cell Lymphocytic Leukemia, B Cell Non-Hodgkin's Lymphoma | Unknown | Ottawa Hospital Research Institute | 160 | 2018-03-01 | 2018-02-07 | |
| Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia AVL-292 - B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Completed | Celgene | 113 | 2011-07-18 | 2019-11-08 |
Lymphoma, B-Cell (5) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Burkitt Lymphoma (1) · Leukemia (1) · Leukemia, B-Cell (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Multiple Myeloma (1) · Waldenstrom Macroglobulinemia (1)
Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Hematologic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Blood Protein Disorders (2) · Cardiovascular Diseases (2) · Hemorrhagic Disorders (2) · Hemostatic Disorders (2) · Leukemia, Lymphoid (2)
Cyclophosphamide (1) · fludarabine (1)
Caribou Biosciences, Inc. (1) · Celgene (1) · Chongqing Precision Biotech Co., Ltd (1) · Ottawa Hospital Research Institute (1) · Peking University (1)
China (2) · United States (2) · Australia (1) · Israel (1)
Harold Atkins, MD FRCP C (1) · Wang Sanbin, MD (1)